ProPharma Group
Improving Patient Health and Safety

Jason DeGoes, COO, ProPharma Group

ProPharma Group works to improve patient health and safety by helping its clients achieve their patient engagement goals. The team at ProPharma does it through one of the company’s key service lines—medical information. This is one of the critical aspects of healthcare that can ensure significant help to patients in need if taken care of appropriately. To ensure the same, the company has communication centres around the world where educated and trained professionals attend to patients’ queries about their therapies, medicines, or anything else that can affect their treatment course. “It’s important because if patients are not confident in a therapy and how to use it, they need to have a place to turn to, and we are one of those places,” adds Jason. Especially in this age, when the world is battling a pandemic, it’s more important than ever to get the desired medical information and support when they cannot immediately visit a physician or a care centre. The ability to connect with somebody by phone or an online medium proves critical in such a scenario.

To consistently support the patients through their contact centres, ProPharma maintains databases that are interlinked. “We collect safety information through contact centers and prepare that on behalf of our clients in a way that after processing, analysing, and assessing it, the knowledge is put into a packaged leaflet with reference safety information summary of product characteristic, which goes back to the patient,” explains Thomas Chatzopoulos, vice president - global pharmacovigilance at ProPharma Group.

ProPharma operates as an ideal partner for pharma and biotech companies, not only because of the support it extends for their patient engagement programs but also because of its ability to assist them with almost all the critical operations they need to carry out. The company also offers a suite of pharmacovigilance (PV) services that prove significant for global pharma companies to develop a product and launch it. From early concept development to each clinical phase, product launch, and even commercialisation, ProPharma helps its clients deal with all the possible challenges.

Thomas Chatzopoulos, Vice President - Global Pharmacovigilance, ProPharma Group

If patients are not confident in therapy and how to use it, they need to have a place to turn to, and we are one of those places

One project that highlights how beneficial these services can be for clients is ProPharma partnered with a small biotech company that has developed a vaccine that will be available shortly. The client had to quickly be prepared to provide high-quality medical information service to their patients and healthcare professionals and ensure that it was carefully monitoring all of the appropriate safety information. ProPharma helped the client with the same and supported them in taking the vaccine to new countries every week. “In such situations, we have to build the program from the ground up and be prepared for what could be a high touch situation,” adds Jason.

In a nutshell, everything the ProPharma team does is aimed at improving patient health and safety. The company is always on the lookout for new ways to enable that mission, including expanding to new geographies and introducing additional services to complement the existing offerings. Recently, ProPharma also announced the acquisition of Diamond Pharma Services, a provider of regulatory affairs, pharmacovigilance, and compliance and quality services. This acquisition is aimed at solidifying ProPharma Group’s position in the market. Another focus area for ProPharma is exploring new technologies such as artificial intelligence and others that can be utilised to collect, assess, and prepare safety data.